FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W83067183> ?p ?o ?g. }

• W83067183 endingPage "50" @default.
• W83067183 startingPage "942" @default.
• W83067183 abstract "Although the vaccine research and development network in the United States remains vibrant, its continued success requires maintaining harmonious interaction among its many components. Changing one component is likely to affect the system overall. An examination of case studies of the development of selected vaccines would allow an examination of the network as a whole. This article presents conclusions drawn from the case study review undertaken.Successful development of vaccines is a time-intensive process requiring years of commitment from a network of scientists and a continuum of regulatory and manufacturing entities. We undertook this work to shed light on how well the vaccine development system in the United States performs.The National Vaccine Advisory Committee examined the research and development pathways of several vaccines that reached licensure expeditiously (hepatitis B vaccine, Haemophilus influenzae type b conjugate vaccines); some that became licensed only after considerable delay (oral typhoid Ty21a vaccine, varicella vaccine); some that are at the point of imminent or recent licensure (reassortant Rhesus rotavirus vaccine, which was licensed by the Food and Drug Administration on August 30, 1998) or near submission for licensure (intranasal cold adapted influenza vaccine); and one for which clinical development is slow because of hurdles that must be overcome (respiratory syncytial virus vaccines).Some common themes emerged from the reviews of these vaccine case histories: the expediting influence of a strong scientific base and rationale; the need for firm quantitation of disease burden and clear identification of target populations; the critical role played by individuals or teams who act as champions to overcome the inevitable obstacles; availability of relevant animal models, high-quality reagents and standardized assays to measure immune response; the absolute requirement for well designed, meticulously executed clinical trials of vaccine safety, immunogenicity, and efficacy; postlicensure measurements of the public health impact of the vaccine and a track record of the vaccine's safety and acceptance with large-scale use; and the critical need for international collaborations to evaluate vaccines against diseases of global importance that are rare in the United States (eg, typhoid fever). It was clear that the critical step-up from bench scale to pilot lots and then to large-scale production, which depends on a small group of highly trained individuals, is often a particularly vulnerable point in the development process.One fundamental lesson learned is that within the varied and comprehensive US vaccine development infrastructure, multiple and rather distinct paths can be followed to reach vaccine licensure. The National Vaccine Advisory Committee review process should be conducted periodically in the future to ascertain that the US vaccine development network, which has been enormously productive heretofore and has played a leadership role globally, is adapting appropriately to ensure that new, safe, and efficacious vaccines become available in a timely manner." @default.
• W83067183 created "2016-06-24" @default.
• W83067183 creator A5000151240 @default.
• W83067183 creator A5001052915 @default.
• W83067183 creator A5004160821 @default.
• W83067183 creator A5013413695 @default.
• W83067183 creator A5013467633 @default.
• W83067183 creator A5025847865 @default.
• W83067183 creator A5032424415 @default.
• W83067183 creator A5033076180 @default.
• W83067183 creator A5033364929 @default.
• W83067183 creator A5035459166 @default.
• W83067183 creator A5036552499 @default.
• W83067183 creator A5046321920 @default.
• W83067183 creator A5050320490 @default.
• W83067183 creator A5051027519 @default.
• W83067183 creator A5054742931 @default.
• W83067183 creator A5061940364 @default.
• W83067183 creator A5071539472 @default.
• W83067183 creator A5082457262 @default.
• W83067183 creator A5090382296 @default.
• W83067183 date "1999-10-01" @default.
• W83067183 modified "2023-09-27" @default.
• W83067183 title "Lessons learned from a review of the development of selected vaccines. National Vaccine Advisory Committee." @default.
• W83067183 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10506239" @default.
• W83067183 hasPublicationYear "1999" @default.
• W83067183 type Work @default.
• W83067183 sameAs 83067183 @default.
• W83067183 citedByCount "6" @default.
• W83067183 countsByYear W830671832016 @default.
• W83067183 countsByYear W830671832020 @default.
• W83067183 countsByYear W830671832022 @default.
• W83067183 crossrefType "journal-article" @default.
• W83067183 hasAuthorship W83067183A5000151240 @default.
• W83067183 hasAuthorship W83067183A5001052915 @default.
• W83067183 hasAuthorship W83067183A5004160821 @default.
• W83067183 hasAuthorship W83067183A5013413695 @default.
• W83067183 hasAuthorship W83067183A5013467633 @default.
• W83067183 hasAuthorship W83067183A5025847865 @default.
• W83067183 hasAuthorship W83067183A5032424415 @default.
• W83067183 hasAuthorship W83067183A5033076180 @default.
• W83067183 hasAuthorship W83067183A5033364929 @default.
• W83067183 hasAuthorship W83067183A5035459166 @default.
• W83067183 hasAuthorship W83067183A5036552499 @default.
• W83067183 hasAuthorship W83067183A5046321920 @default.
• W83067183 hasAuthorship W83067183A5050320490 @default.
• W83067183 hasAuthorship W83067183A5051027519 @default.
• W83067183 hasAuthorship W83067183A5054742931 @default.
• W83067183 hasAuthorship W83067183A5061940364 @default.
• W83067183 hasAuthorship W83067183A5071539472 @default.
• W83067183 hasAuthorship W83067183A5082457262 @default.
• W83067183 hasAuthorship W83067183A5090382296 @default.
• W83067183 hasConcept C133239900 @default.
• W83067183 hasConcept C147483822 @default.
• W83067183 hasConcept C159047783 @default.
• W83067183 hasConcept C17744445 @default.
• W83067183 hasConcept C203014093 @default.
• W83067183 hasConcept C22070199 @default.
• W83067183 hasConcept C2522874641 @default.
• W83067183 hasConcept C2777227250 @default.
• W83067183 hasConcept C2780454893 @default.
• W83067183 hasConcept C2780689484 @default.
• W83067183 hasConcept C2780801004 @default.
• W83067183 hasConcept C2781234862 @default.
• W83067183 hasConcept C2781367151 @default.
• W83067183 hasConcept C3017489713 @default.
• W83067183 hasConcept C3116431 @default.
• W83067183 hasConcept C509550671 @default.
• W83067183 hasConcept C71924100 @default.
• W83067183 hasConceptScore W83067183C133239900 @default.
• W83067183 hasConceptScore W83067183C147483822 @default.
• W83067183 hasConceptScore W83067183C159047783 @default.
• W83067183 hasConceptScore W83067183C17744445 @default.
• W83067183 hasConceptScore W83067183C203014093 @default.
• W83067183 hasConceptScore W83067183C22070199 @default.
• W83067183 hasConceptScore W83067183C2522874641 @default.
• W83067183 hasConceptScore W83067183C2777227250 @default.
• W83067183 hasConceptScore W83067183C2780454893 @default.
• W83067183 hasConceptScore W83067183C2780689484 @default.
• W83067183 hasConceptScore W83067183C2780801004 @default.
• W83067183 hasConceptScore W83067183C2781234862 @default.
• W83067183 hasConceptScore W83067183C2781367151 @default.
• W83067183 hasConceptScore W83067183C3017489713 @default.
• W83067183 hasConceptScore W83067183C3116431 @default.
• W83067183 hasConceptScore W83067183C509550671 @default.
• W83067183 hasConceptScore W83067183C71924100 @default.
• W83067183 hasIssue "4 Pt 1" @default.
• W83067183 hasLocation W830671831 @default.
• W83067183 hasOpenAccess W83067183 @default.
• W83067183 hasPrimaryLocation W830671831 @default.
• W83067183 hasRelatedWork W1970249589 @default.
• W83067183 hasRelatedWork W2025524418 @default.
• W83067183 hasRelatedWork W2090517162 @default.
• W83067183 hasRelatedWork W2109057963 @default.
• W83067183 hasRelatedWork W2487703924 @default.
• W83067183 hasRelatedWork W2791290311 @default.
• W83067183 hasRelatedWork W2917832416 @default.
• W83067183 hasRelatedWork W3199527886 @default.

• next